- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 31st, 2005
Anadis Ltd and Starpharma Holdings Limited announced today that they have established a partnership to investigate applications of their combined technologies to respiratory protection and biodefense.
This research involves the use of polyclonal antibodies, harvested from bovine colostrum and combined with Starpharma’s nano-scale dendrimer molecules to provide immediate short term respiratory protection from airborne biological agents such as Anthrax and Plague.
|Related News Press|
Metal oxide sandwiches: New option to manipulate properties of interfaces February 8th, 2016
Canadian physicists discover new properties of superconductivity February 8th, 2016
Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016
From allergens to anodes: Pollen derived battery electrodes February 8th, 2016